Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Knight Therapeutics (TSE:GUD)
TSX:GUD
RESEARCH TOOLSreports
Holding TSE:GUD?
Track your performance easily
See the Price Targets and Ratings of:
GUD Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GUD Stock 12 Month Forecast
Average Price Target
C$6.56
▲(24.76% Upside)
| Highest Price TargetC$6.98 | Average Price TargetC$6.56 | Lowest Price TargetC$6.23 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
Reiterated
11/08/24
Research Capital
Downgraded
11/07/24
RBC Capital
Reiterated
11/07/24
Bloom Burton
C$9
Buy
71.10%
Upside
Reiterated
08/09/24
David Martin PhD Endorses Knight Therapeutics with a Buy Rating Amidst Strong Growth and Resilience
Raymond James
C$7.5→C$8
Buy
52.09%
Upside
Reiterated
08/09/24
Knight Therapeutics price target raised to C$8 from C$7.50 at Raymond JamesKnight Therapeutics price target raised to C$8 from C$7.50 at Raymond James
Canaccord Genuity
C$7.25
Buy
37.83%
Upside
Initiated
04/15/24
Knight Therapeutics resumed with a Buy at CanaccordKnight Therapeutics resumed with a Buy at Canaccord
Best Analysts Covering Knight Therapeutics
Which Analyst Should I Follow If I Want to Buy TSE:GUD and Sell After:
1 Month
xxx
Success Rate
8/13 ratings generated profit
Average Return
+2.13%
initiated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.54% of your transactions generating a profit, with an average return of +2.13% per trade.
3 Months
xxx
Success Rate
8/13 ratings generated profit
Average Return
+0.52%
initiated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +0.52% per trade.
1 Year
Success Rate
6/18 ratings generated profit
Average Return
-8.17%
reiterated a buy rating 3 months ago
Copying David Martin PhD's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -8.17% per trade.
2 Years
xxx
Success Rate
6/19 ratings generated profit
Average Return
-7.57%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 31.58% of your transactions generating a profit, with an average return of -7.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GUD Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Aug 24
Nov 24
Strong Buy
5
5
7
8
9
Buy
0
0
0
0
0
Hold
1
1
2
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
6
9
10
12
Each month's total comprises the sum of three months' worth of ratings.
GUD Financial Forecast
GUD Stock Forecast FAQ
What is TSE:GUD’s average 12-month price target, according to analysts?
Based on analyst ratings, Knight Therapeutics’s 12-month average price target is C$6.56.
What is TSE:GUD’s upside potential, based on the analysts’ average price target?
Knight Therapeutics has 24.76% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:GUD a Buy, Sell or Hold?
Knight Therapeutics has a consensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Knight Therapeutics’s price target?
The average price target for Knight Therapeutics is C$6.56. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$6.98 ,the lowest forecast is C$6.23. The average price target represents 24.76% Increase from the current price of C$5.26.
The highest analyst price target is C$6.98 ,the lowest forecast is C$6.23. The average price target represents 24.76% Increase from the current price of C$5.26.
What do analysts say about Knight Therapeutics?
Knight Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of TSE:GUD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.